Genome Editing Market is expected to reach USD XX Billion by 2026 from USD 4.28 Billion in 2019 at a CAGR of XX % (Detailed analysis of the market CAGR is provided in the report). The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology :- Request Free Sample Report Primarily genome editing is a type of genetic engineering in which DNA is inserted, modified, deleted or replaced in the genome of a living organism. This technology is also used for the disease extinction through direct correction of disturbances in genes, improving the immune response and alteration of pathogen targets. The genome editing market based on technology has been segmented into CRISPR, TALEN, ZFN, antisense and other technologies. The CRISPR segment is expected to be one of the major contributors for the market during the forecast period. The growth of this segment is attributed to the convenience of CRISPR technology. Based on application, the Genome Editing market is categorized into cell line engineering, genetic engineering, and other applications. The cell line engineering segment is estimated to have one of the largest shares of the market. This is due to the growing global awareness of stem cell therapies and increasing government and private funding. The genome editing market based on end user has been into pharmaceutical and biotechnology companies, academic & government research institutes and contract research organizations. The pharmaceutical and biotechnology companies segment is expected to hold one of the largest shares of the market during the forecast period. The growth of this segment is attributed to the rising incidence of infectious diseases, cancer, and other genetic disorders are tend to increase the research activities globally, thereby driving the growth of this segment. Geographically, the genome editing market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to be one of the largest markets for Genome Editing followed by Europe. The growth of this region is attributed to the improvement of gene therapy in the US, increasing incidence of infectious diseases and the rising use of genetically modified yields.
Genome Editing Market Key Highlights:• Genome editing silicone market analysis and forecast, in terms of volume and value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the genome editing market. • Genome editing market segmentation on the basis of technology, application, end user and geography (country-wise) has been provided. • Genome editing market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of the study. • Genome editing market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the genome editing market are also profiled.
Genome Editing Market Research Methodology:The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Genome Editing Market.
Some of them operating in the market are given underneath:• Thermo Fisher Scientific (US) • Horizon Discovery Group (UK) • Merck (Germany) • Genscript (US) • Integrated DNA Technologies (US) • Sangamo Biosciences (US) • Lonza (Switzerland) • Origene Technologies (US) • New England Biolabs (US) • Transposagen Biopharmaceuticals (US)
Key Target Audience:• Suppliers and distributors of genome editing technologies • Research institutes • Vendors or service providers of genome editing
Scope of the Genome Editing Market: Inquire before buyingThe research report segments the genome editing market based on technology, application, end user and geography
Genome Editing Market, by Technology:• CRISPR • TALEN • ZFN • Antisense • Other technologies
Genome Editing Market, by Application:• Cell line Engineering • Genetic Engineering • Other Applications
Genome Editing Market, by End User:• Biotechnology & Pharmaceutical Companies • Academic & Research Institutes • Contract Research Organizations
Genome Editing Market, by Geography:• North America • Europe • Asia Pacific • Middle East & Africa • Latin America
Geographic Analysis:• Breakdown of North America Genome Editing Market • Breakdown of Europe Genome Editing Market • Breakdown of Asia Pacific Genome Editing Market • Breakdown of Middle East & Africa Genome Editing Market • Breakdown of Latin America Genome Editing Market
Available Customization:Maximize Market Research offers customization of reports according to the specific requirement of our clients
Genome Editing Market1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GENOME EDITING MARKET, BY TECHNOLOGY (2019-2026) 5.1. Introduction 5.2. Genome Editing Market, by CRISPR 5.2.1. CRISPR Market Overview 5.2.2. CRISPR Market Size & Forecast 5.3. Genome Editing Market, by TALEN 5.3.1. TALEN Market Overview 5.3.2. TALEN Market Size & Forecast 5.4. Genome Editing Market, by ZFN 5.4.1. ZFN Market Overview 5.4.2. ZFN Market Size & Forecast 5.5. Genome Editing Market, by Antisense 5.5.1. Antisense Market Overview 5.5.2. Antisense Market Size & Forecast 5.6. Genome Editing Market, by Other Technologies 5.6.1. Other Technologies Market Overview 5.6.2. Other Technologies Market Size & Forecast 6. GENOME EDITING MARKET, BY APPLICATION (2019-2026) 6.1. Introduction 6.2. Genome Editing Market, by Cell Line Engineering 6.2.1. Cell Line Engineering Market Overview 6.2.2. Cell Line Engineering Market Size & Forecast 6.3. Genome Editing Market, by Genetic Engineering 6.3.1. Genetic Engineering Market Overview 6.3.2. Genetic Engineering Market Size & Forecast 22.214.171.124. Animal Genetic Engineering 126.96.36.199. Plant Genetic Engineering 6.4. Genome Editing Market, by Other Applications 6.4.1. Other Applications Market Overview 6.4.2. Other Applications Market Size & Forecast 7. GENOME EDITING MARKET, BY END USER (2019-2026) 7.1. Introduction 7.2. Genome Editing Market, by Biotechnology & Pharmaceutical Companies 7.2.1. Biotechnology & Pharmaceutical Companies Market Overview 7.2.2. Biotechnology & Pharmaceutical Companies Market Size & Forecast 7.3. Genome Editing Market, by Academic & Government Research Institutes 7.3.1. Academic & Government Research Institutes Market Overview 7.3.2. Academic & Government Research Institutes Market Size & Forecast 7.4. Genome Editing Market, by Contract Research Organizations 7.4.1. Contract Research Organizations Market Overview 7.4.2. Contract Research Organizations Market Size & Forecast 8. GENOME EDITING MARKET, BY GEOGRAPHY (2019-2026) 8.1. North America Genome Editing Market 8.1.1. North America Genome Editing Market, by Technology 8.1.2. North America Genome Editing Market, by Application 8.1.3. North America Genome Editing Market, by End-user 8.1.4. North America Genome Editing Market, by Region 188.8.131.52. U.S. Genome Editing Market 184.108.40.206. Canada Genome Editing Market 220.127.116.11. Rest of North America Genome Editing Market 8.2. Europe Genome Editing Market 8.2.1. Europe Genome Editing Market, by Technology 8.2.2. Europe Genome Editing Market, by Application 8.2.3. Europe Genome Editing Market, by End-user 8.2.4. Europe Genome Editing Market, by Region 18.104.22.168. France Genome Editing Market 22.214.171.124. Germany Genome Editing Market 126.96.36.199. U.K .Genome Editing Market 188.8.131.52. Rest of Europe Genome Editing Market 8.3. Asia Pacific Genome Editing Market 8.3.1. Asia-Pacific Genome Editing Market, by Technology 8.3.2. Asia-Pacific Genome Editing Market, by Application 8.3.3. Asia-Pacific Genome Editing Market, by End-user 8.3.4. Asia-Pacific Genome Editing Market, by Region 184.108.40.206. China Genome Editing Market 220.127.116.11. Japan Genome Editing Market 18.104.22.168. India Genome Editing Market 22.214.171.124. Australia Genome Editing Market 126.96.36.199. South Korea Genome Editing Market 188.8.131.52. Rest of Asia Pacific Genome Editing Market 8.4. Middle East & Africa Genome Editing Market 8.4.1. Middle East & Africa Genome Editing Market, by Technology 8.4.2. Middle East & Africa Genome Editing Market, by Application 8.4.3. Middle East & Africa Genome Editing Market, by End-user 8.4.4. Middle East & Africa Genome Editing Market, by Region 184.108.40.206. South Africa Genome Editing Market 220.127.116.11. Egypt Genome Editing Market 18.104.22.168. Nigeria Genome Editing Market 22.214.171.124. Rest of Middle East & Africa Genome Editing Market 8.5. Latin America Genome Editing Market 8.5.1. Latin America Genome Editing Market, by Technology 8.5.2. Latin America Genome Editing Market, by Application 8.5.3. Latin America Genome Editing Market, by End-user 8.5.4. Latin America Genome Editing Market, by Region 126.96.36.199. Brazil Genome Editing Market 188.8.131.52. Argentina Genome Editing Market 184.108.40.206. Columbia Genome Editing Market 220.127.116.11. Mexico Genome Editing Market 18.104.22.168. Rest of Latin America Genome Editing Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Thermo Fisher Scientific 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.2 Horizon Discovery Group 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.3 Merck 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.4 Genscript 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.5 Integrated DNA Technologies 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.6 Sangamo Biosciences 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.7 Lonza 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.8 Origene Technologies 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.9 New England Biolabs 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.10 Transposagen Biopharmaceuticals 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments